[A case of long-term survivor after combined modality therapy for brain metastasis of bladder carcinoma]

Hinyokika Kiyo. 2012 Oct;58(10):553-6.
[Article in Japanese]

Abstract

A 75-year-old man with advanced bladder cancer (cT4N1M0) received three courses of systemic chemotherapy with Methotrexate, Epirubicin and Nedaplatin (MEN). His metastatic lymph node completely disappeared. We performed total cystectomy. Three months after the surgery, he complained of neck pain and nausea. Brain magnetic resonance imaging (MRI) revealed a 3 cm tumor in his right cerebella and a 5 mm tumor in left parietal lobe. He underwent surgical resection of the right cerebellar tumor and a gamma knife therapy for the left parietal tumor. Pathological diagnosis was metastatic urothelial carcinoma. We performed three additional courses of chemotherapy of MEN. He has been well without local recurrence or distant metastasis for 18 months.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Brain Neoplasms / secondary*
  • Carcinoma, Transitional Cell / pathology*
  • Carcinoma, Transitional Cell / therapy*
  • Combined Modality Therapy
  • Humans
  • Male
  • Survivors
  • Urinary Bladder Neoplasms / pathology*
  • Urinary Bladder Neoplasms / therapy*